JSPR · Forms 3, 4, 5
Insider trades at Jasper Therapeutics, Inc.
No open-market insider buys or sells at Jasper Therapeutics, Inc. in the last 90 days; 9 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Jasper Therapeutics, Inc. (JSPR) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Thomas G Wiggans | Director | Options or other derivatives | Form 4 | ||||
| Svetlana Lucas | Director | Options or other derivatives | Form 4 | ||||
| Patrick J Crutcher | Director | Options or other derivatives | Form 4 | ||||
| Kurt Von Emster | Director | Options or other derivatives | Form 4 | ||||
| Judith Anne Shizuru | Director | Options or other derivatives | Form 4 | ||||
| Greg Keenan | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Matthew E Ros | Chief Operating Officer | Options or other derivatives | Form 4 | ||||
| Wenru Song | EVP, Head of R&D | Became an insider (Form 3) | Form 3 | ||||
| Matthew E Ros | Chief Operating Officer | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.